alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Experimental Radiation Injuries in 1 studies
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Que, M | 1 |
Schiene, K | 1 |
Witte, OW | 1 |
Zilles, K | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Noninvasive Brain Stimulation Training to Help Recover Brain-related Symptoms[NCT03228472] | 100 participants (Anticipated) | Interventional | 2017-11-22 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Experimental Radiation Injuries
Article | Year |
---|---|
Widespread up-regulation of N-methyl-D-aspartate receptors after focal photothrombotic lesion in rat brain.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Autoradiography; Brain Ischemia; | 1999 |